G

GemPharmatech Co Ltd
SSE:688046

Watchlist Manager
GemPharmatech Co Ltd
SSE:688046
Watchlist
Price: 15.37 CNY 1.79% Market Closed
Market Cap: 3.1B CNY

Net Margin
GemPharmatech Co Ltd

16.1%
Current
24%
Average
1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
16.1%
=
Net Income
121.5m
/
Revenue
752.7m

Net Margin Across Competitors

No Stocks Found

GemPharmatech Co Ltd
Glance View

GemPharmatech Co., Ltd. engages in research and development, manufacture, and sale of experimental mouse models. The company is headquartered in Nanjing, Jiangsu and currently employs 1,342 full-time employees. The company went IPO on 2022-04-25. The firm uses gene-editing and other technologies to produce mouse models. The firm also involves in the business of customized model breeding, drug efficacy analysis, and model customization. The Company’s products are mainly used to satisfy the experimental demands in the fields of gene function cognition, disease mechanisms analysis, drug target discovery, and other fundamental researches.

Intrinsic Value
20.03 CNY
Undervaluation 23%
Intrinsic Value
Price
G
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
16.1%
=
Net Income
121.5m
/
Revenue
752.7m
What is the Net Margin of GemPharmatech Co Ltd?

Based on GemPharmatech Co Ltd's most recent financial statements, the company has Net Margin of 16.1%.

Back to Top